pharma news today glp-1 obesity What is the pipeline for future medications for obesity? GLP-1 Agonists Weight Loss Drugs

Description

Mechanism of action of GLP-1 receptor agonists: Direct receptor binding These medications bind specifically to GLP-1 receptors on pancreatic beta cells, stimulating insulin secretion in a glucose-dependent manner (meaning they work when blood glucose is elevated)

LISTEN on the Audacy App Tell your Smart Speaker to "PLAY 1080 KRLD" Sign Up to receive our KRLD Insider Newsletter for more news Follow us on Facebook | Twitter | Instagram | YouTube

Thats why weve created a free leaflet: GLP-1s and Lifestyle What I Need to Know

If headaches persist beyond two weeks or worsen, contact your PlexusDx clinician to review your dosing schedule and hydration plan

Despite the limitations of the single-blind design in this clinical study, the advantages in exenatide-treated group in both cognitive and motor functions persisted in the follow-up study after a 12-mo wash-out period. 99 This suggests disease-modifying effects of exenatide, and the results are encouraging enough that a subsequent double-blind clinical study (NCT01971242) was initiated by the same investigators using a sustained release formulation of exenatide ( Bydureon : 2 mg administered subcutaneously once weekly) to evaluate in a similar group of PD subjects over a similar duration of time